1. Identifying the "Silent" RisksHigh cholesterol isn't always about what’s on the plate. Conditions like Familial Hypercholesterolemia (FH) often remain asymptomatic until a major cardiac event occurs. By identifying genetic markers for FH or hereditary cardiomyopathies, providers can initiate earlier interventions and personalized monitoring protocols.
2. Pharmacogenomics (PGx): Precision PrescribingGeneric prescribing can lead to adverse drug reactions (ADRs) or treatment failure. PGx testing analyzes how a patient metabolizes specific cardiac medications:
- Statins: Genetic variants can predict the likelihood of statin-associated muscle pain (myopathy), improving long-term adherence.
- Antiplatelets (e.g., Clopidogrel): Some patients carry variants that render standard doses ineffective, significantly increasing the risk of secondary stroke or heart attack.
- Beta-Blockers: PGx helps clinicians find the "Goldilocks" dose—optimal efficacy with minimal side effects—right from the start.

Gene by Gene
Company News & Press Releases
Gene By Gene is a world leader in genetic testing services with over 20 years of experience. Our laboratory holds accreditation from multiple agencies, including CAP, CLIA, California Department of Public Health, and AABB. With a cutting-edge laboratory and highly trained team of experts, we are committed to excellence in the field of genetic analysis.